Discover the PCG Difference!
Pharma Industry publishes our RBQM article
Get up to speed on what RBQM means for you
Are you wondering how introducing risk-based quality management (RBQM) into your clinical trials might affect your business? Gunnar Danielsson’s latest article is now published in Pharma Industry and you can discover the potential for RBQM to help you streamline study design and reduce unnecessary costs. The PI article is published in Swedish.
Gunnar Danielsson, our Senior Regulatory Advisor, will also be talking about RBQM at the Pharma Outsourcing meeting in Stockholm on December 8th. Contact us to find out more about our Advisory services or to set up a meeting with our team.